ALNY
Price
$331.91
Change
+$2.14 (+0.65%)
Updated
Jul 3 closing price
Capitalization
43.28B
25 days until earnings call
BEAM
Price
$20.01
Change
+$0.13 (+0.65%)
Updated
Jul 3 closing price
Capitalization
2.01B
37 days until earnings call
Interact to see
Advertisement

ALNY vs BEAM

Header iconALNY vs BEAM Comparison
Open Charts ALNY vs BEAMBanner chart's image
Alnylam Pharmaceuticals
Price$331.91
Change+$2.14 (+0.65%)
Volume$431.16K
Capitalization43.28B
Beam Therapeutics
Price$20.01
Change+$0.13 (+0.65%)
Volume$1.36M
Capitalization2.01B
ALNY vs BEAM Comparison Chart in %
Loading...
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALNY vs. BEAM commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALNY is a StrongBuy and BEAM is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ALNY: $331.91 vs. BEAM: $20.01)
Brand notoriety: ALNY and BEAM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALNY: 46% vs. BEAM: 72%
Market capitalization -- ALNY: $43.28B vs. BEAM: $2.01B
ALNY [@Biotechnology] is valued at $43.28B. BEAM’s [@Biotechnology] market capitalization is $2.01B. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALNY’s FA Score shows that 1 FA rating(s) are green whileBEAM’s FA Score has 1 green FA rating(s).

  • ALNY’s FA Score: 1 green, 4 red.
  • BEAM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALNY and BEAM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALNY’s TA Score shows that 4 TA indicator(s) are bullish while BEAM’s TA Score has 4 bullish TA indicator(s).

  • ALNY’s TA Score: 4 bullish, 4 bearish.
  • BEAM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ALNY is a better buy in the short-term than BEAM.

Price Growth

ALNY (@Biotechnology) experienced а +4.29% price change this week, while BEAM (@Biotechnology) price change was +16.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

ALNY is expected to report earnings on Oct 23, 2025.

BEAM is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALNY($43.3B) has a higher market cap than BEAM($2.01B). ALNY YTD gains are higher at: 41.052 vs. BEAM (-19.315). ALNY has higher annual earnings (EBITDA): -152.58M vs. BEAM (-399.03M). ALNY has more cash in the bank: 2.63B vs. BEAM (1.22B). BEAM has less debt than ALNY: BEAM (158M) vs ALNY (1.3B). ALNY has higher revenues than BEAM: ALNY (2.35B) vs BEAM (63.6M).
ALNYBEAMALNY / BEAM
Capitalization43.3B2.01B2,152%
EBITDA-152.58M-399.03M38%
Gain YTD41.052-19.315-213%
P/E RatioN/AN/A-
Revenue2.35B63.6M3,692%
Total Cash2.63B1.22B216%
Total Debt1.3B158M824%
FUNDAMENTALS RATINGS
ALNY: Fundamental Ratings
ALNY
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
PROFIT vs RISK RATING
1..100
18
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALNYBEAM
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
MACD
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
72%
Bullish Trend 4 days ago
80%
Advances
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 11 days ago
66%
Bearish Trend 14 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ALNY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PVAL41.070.23
+0.56%
Putnam Focused Large Cap Value ETF
MART36.130.16
+0.45%
AllianzIM U.S. Large Cp Buffer10 Mar ETF
MFSB24.89-0.03
-0.13%
MFS Active Core Plus Bond ETF
UGL35.17-0.09
-0.26%
ProShares Ultra Gold
VFL9.73-0.05
-0.51%
abrdn National Municipal Income Fund

ALNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALNY has been loosely correlated with IONS. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if ALNY jumps, then IONS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALNY
1D Price
Change %
ALNY100%
+0.65%
IONS - ALNY
53%
Loosely correlated
-1.35%
SGMO - ALNY
42%
Loosely correlated
-1.51%
RARE - ALNY
37%
Loosely correlated
+1.14%
ALLO - ALNY
37%
Loosely correlated
-0.83%
INSM - ALNY
37%
Loosely correlated
N/A
More